Contemporary Intravenous Antiplatelet Strategies in PCI
Sponsored by: Chiesi
This satellite will include a focus on understanding why effective platelet inhibition is needed during PCI; reviewing current guidelines and options for antiplatelet therapy in the cath lab, and the role for intravenous platelet inhibition. Multiple cases will be presented with a focus on identifying appropriate high-risk patient characteristics, including medical history, clinical presentation, and angiographic risk factors.
Introductory Remarks
Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Covington, KY
Panel Discussion
Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Covington, KY and Garrett B. Wong, M.D., UC Davis Medical Center, Sacramento, CA